Anti-Retroviral Treatment in dr. Sardjito Central General Hospital Yogyakarta

Background: Adverse cutaneous drug reactions (ACDRs) affect 2-3% of hospitalized patients globally, wherein approximately 2% (1 in 1,000 cases) accounted for a severe form of cutaneous drug reactions. Out of all dermatologic diagnoses recorded by HIV patients, eight-point twenty-five percent of pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Labitta Pachira Aquaira, Sri Awalia Febriana, Nurwestu Rusetiyanti
Format: Article
Language:Indonesian
Published: Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga 2024-11-01
Series:Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology)
Subjects:
Online Access:https://e-journal.unair.ac.id/BIKK/article/view/56993
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850117746595987456
author Labitta Pachira Aquaira
Sri Awalia Febriana
Nurwestu Rusetiyanti
author_facet Labitta Pachira Aquaira
Sri Awalia Febriana
Nurwestu Rusetiyanti
author_sort Labitta Pachira Aquaira
collection DOAJ
description Background: Adverse cutaneous drug reactions (ACDRs) affect 2-3% of hospitalized patients globally, wherein approximately 2% (1 in 1,000 cases) accounted for a severe form of cutaneous drug reactions. Out of all dermatologic diagnoses recorded by HIV patients, eight-point twenty-five percent of patients feature ACDRs, indicating that these patients are 100 times more inclined to develop unfortunate, severe reactions to anti-retroviral treatment. Therefore, there is an urgency in identifying the prevalence of ACDRs in HIV patients taking anti-retroviral treatment. Purpose: The aim of this study is to calculate the prevalence of anti-retroviral drug-induced ACDRs in HIV-positive patients in Central General Hospital, in the time period of January 2015 to December 2017. Methods: This study analyzed inpatient and outpatient medical records from January 2015 to December 2017 in the Dermatology and Venereology Department of dr. Sardjito Central General Hospital, which recorded ART-induced ACDRs manifestations. Result: This study revealed a prevalence of 0.095% of ACDRs as a result of ART administration, with 1.5% HIV-positive patients affected by ACDRs in response to ART medication. A m sex ratio of 2:1 with an average age of 30.4 ± 5.94 years old was found. The most predominant type of ACDR found in HIV-positive patients receiving ART was maculopapular rash (46.7%), while the most common type of drug within the ART regimen to cause such ACDR was Nevirapine (25.8%). Discussion: Nevirapine was the most common type of causative drug, for monotherapy (22.6%) and polytherapy (25.8%).
format Article
id doaj-art-411fef930cf84cbcb78bf60e2f1fdf47
institution OA Journals
issn 1978-4279
2549-4082
language Indonesian
publishDate 2024-11-01
publisher Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga
record_format Article
series Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology)
spelling doaj-art-411fef930cf84cbcb78bf60e2f1fdf472025-08-20T02:36:02ZindDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas AirlanggaBerkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology)1978-42792549-40822024-11-0136316216710.20473/bikk.V36.3.2024.162-16755158Anti-Retroviral Treatment in dr. Sardjito Central General Hospital YogyakartaLabitta Pachira Aquaira0Sri Awalia Febriana1https://orcid.org/0000-0002-8209-2820Nurwestu Rusetiyanti2https://orcid.org/0009-0008-1950-7764Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, IndonesiaDepartment of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, IndonesiaDepartment of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, IndonesiaBackground: Adverse cutaneous drug reactions (ACDRs) affect 2-3% of hospitalized patients globally, wherein approximately 2% (1 in 1,000 cases) accounted for a severe form of cutaneous drug reactions. Out of all dermatologic diagnoses recorded by HIV patients, eight-point twenty-five percent of patients feature ACDRs, indicating that these patients are 100 times more inclined to develop unfortunate, severe reactions to anti-retroviral treatment. Therefore, there is an urgency in identifying the prevalence of ACDRs in HIV patients taking anti-retroviral treatment. Purpose: The aim of this study is to calculate the prevalence of anti-retroviral drug-induced ACDRs in HIV-positive patients in Central General Hospital, in the time period of January 2015 to December 2017. Methods: This study analyzed inpatient and outpatient medical records from January 2015 to December 2017 in the Dermatology and Venereology Department of dr. Sardjito Central General Hospital, which recorded ART-induced ACDRs manifestations. Result: This study revealed a prevalence of 0.095% of ACDRs as a result of ART administration, with 1.5% HIV-positive patients affected by ACDRs in response to ART medication. A m sex ratio of 2:1 with an average age of 30.4 ± 5.94 years old was found. The most predominant type of ACDR found in HIV-positive patients receiving ART was maculopapular rash (46.7%), while the most common type of drug within the ART regimen to cause such ACDR was Nevirapine (25.8%). Discussion: Nevirapine was the most common type of causative drug, for monotherapy (22.6%) and polytherapy (25.8%).https://e-journal.unair.ac.id/BIKK/article/view/56993adverse cutaneous drug reactionsart regimennevirapinemaculopapular rashhiv-positive patients
spellingShingle Labitta Pachira Aquaira
Sri Awalia Febriana
Nurwestu Rusetiyanti
Anti-Retroviral Treatment in dr. Sardjito Central General Hospital Yogyakarta
Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology)
adverse cutaneous drug reactions
art regimen
nevirapine
maculopapular rash
hiv-positive patients
title Anti-Retroviral Treatment in dr. Sardjito Central General Hospital Yogyakarta
title_full Anti-Retroviral Treatment in dr. Sardjito Central General Hospital Yogyakarta
title_fullStr Anti-Retroviral Treatment in dr. Sardjito Central General Hospital Yogyakarta
title_full_unstemmed Anti-Retroviral Treatment in dr. Sardjito Central General Hospital Yogyakarta
title_short Anti-Retroviral Treatment in dr. Sardjito Central General Hospital Yogyakarta
title_sort anti retroviral treatment in dr sardjito central general hospital yogyakarta
topic adverse cutaneous drug reactions
art regimen
nevirapine
maculopapular rash
hiv-positive patients
url https://e-journal.unair.ac.id/BIKK/article/view/56993
work_keys_str_mv AT labittapachiraaquaira antiretroviraltreatmentindrsardjitocentralgeneralhospitalyogyakarta
AT sriawaliafebriana antiretroviraltreatmentindrsardjitocentralgeneralhospitalyogyakarta
AT nurwesturusetiyanti antiretroviraltreatmentindrsardjitocentralgeneralhospitalyogyakarta